A New Hope for Madeline – by PSY-23
After a lifetime of problems, a glimmer of hope began to shine on the family
Treatment of Tourette syndrome with cannabinoids
Cannabinoids have been used for hundred of years for medical purposes. To day, the cannabinoid delta-9-tetrahydrocannabinol (THC) and the cannabis extract nabiximols are approved for the treatment of nausea, anorexia and spasticity, respectively. In Tourette syndrome (TS) several anecdotal reports provided evidence that marijuana might be effective not only in the suppression of tics, but also in the treatment of associated behavioural problems.
First Marijuana ‘Breathalyzer’ Test has arrived from Hound Labs
“When you find THC in breath, you can be pretty darn sure that somebody smoked pot in the last couple of hours,”
Topical Medical Cannabis: A New Treatment for Wound Pain-Three Cases of Pyoderma Gangrenosum
Pain associated with integumentary wounds is highly prevalent, yet it remains an area of significant unmet need within health care. Currently, systemically administered opioids are the mainstay of treatment. However, recent publications are casting opioids in a negative light given their high side effect profile, inhibition of wound healing, and association with accidental overdose, incidents that are frequently fatal.
One puff of cannabis ‘could be all that’s needed
After just two puffs patients felt less anxious and after ten puffs they were less stressed
Harvard Researchers on Lung Cancer: THC Cuts Tumor Growth in Half
Lung cancer is the most aggressive form of these tumors and tends to spread quickly.
Kansas Rejects THC, Supports CBD in Medical Marijuana Legalization Vote
The Kansas House of Representatives shot down an amendment to legalize medical marijuana on Monday, rejecting the Kansas Safe Access Act by a vote of 54-69.
Medical Cannabis for Neuropathic Pain
Many cultures throughout history have used cannabis to treat a variety of painful ailments. Neuropathic pain is a complicated condition that is challenging to treat with our current medications. Recent scientific discovery has elucidated the intricate role of the endocannabinoid system in the pathophysiology of neuropathic pain. As societal perceptions change, and legislation on medical cannabis relaxes, there is growing interest in the use of medical cannabis for neuropathic pain. The results suggest medical cannabis may be as tolerable and effective as current neuropathic agents; however, more studies are needed to determine the long-term effects of medical cannabis use. Furthermore, continued research to optimize dosing, cannabinoid ratios, and alternate routes of administration may help to refine the therapeutic role of medical cannabis for neuropathic pain.
Stronger cannabis linked to rise in demand for drug treatment programmes
“This is the first study to provide evidence for an association between changes in potency and health-related outcomes,” said Tom Freeman, an addiction scientist at King’s.
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Medical marijuana continues to gain acceptance and become legalized in many states. Various species of the marijuana plant have been cultivated, and this plant can contain up to 100 active compounds known as cannabinoids. Two cannabinoids seem the most clinically relevant: Δ9-tetrahydrocannabinol (THC), which tends to produce the psychotropic effects commonly associated with marijuana, and cannabidiol (CBD), which may produce therapeutic effects without appreciable psychoactive properties. Although there is still a need for randomized controlled trials, preliminary studies have suggested that medical marijuana and related cannabinoids may be beneficial in treating people with chronic pain, inflammation, spasticity and other conditions.